You have 9 free searches left this month | for more free features.

best1

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Study of BEST1 Vitelliform Macular Dystrophy

Recruiting
  • Best Vitelliform Macular Dystrophy
  • Retinitis Pigmentosa
  • Natural History Study
  • New York, New York
  • +2 more
Mar 30, 2023

Prostate Cancer Trial in Canada, United States (Best Systemic Therapy (BST), Best Systemic Therapy (BST) + Surgery or Radiation

Active, not recruiting
  • Prostate Cancer
  • Best Systemic Therapy (BST)
  • +3 more
  • San Francisco, California
  • +3 more
Dec 5, 2022

Parkinson Disease Trial in Montreal, Montréal (Heel2Toe[TM] sensor)

Enrolling by invitation
  • Parkinson Disease
  • Heel2Toe[TM] sensor
  • Montreal, Quebec, Canada
  • +1 more
Mar 24, 2023

COVID-19, ARDS, Acute Respiratory Distress Syndrome Trial (Human umbilical cord mesenchymal stem cells + best supportive care,

Not yet recruiting
  • COVID-19
  • +2 more
  • Human umbilical cord mesenchymal stem cells + best supportive care
  • Placebo control + best supportive care
  • (no location specified)
Aug 9, 2022

Stroke, Acute Trial in Karachi (Sodium Chloride 0.9% infusion alone or in combination with Sodim acetate with normal saline in a

Recruiting
  • Stroke, Acute
  • Sodium Chloride 0.9% infusion alone or in combination with Sodim acetate with normal saline in a ratio 1;1, 2;1 and 3;1
  • Karachi, Pakistan
    Aga Khan University
May 19, 2023

Perioperative Care in the Cancer Patient -1, ARCA-1 Study

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Best Practice
  • Medical Chart Review
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

EEG Trial in Montreal (Set For Variability, Current Best Practices)

Recruiting
  • EEG
  • Set For Variability
  • Current Best Practices
  • Montreal, Quebec, Canada
    McGill University
Sep 23, 2022

Gambling Disorder Trial in Lethbridge (Contingency Management, Cognitive Behavioural Therapy)

Recruiting
  • Gambling Disorder
  • Contingency Management
  • Cognitive Behavioural Therapy
  • Lethbridge, Alberta, Canada
    University of Lethbridge
Nov 17, 2022

Depth of Small Bowel Insertion at Push Enteroscopy by Using

Active, not recruiting
  • Obscure Gastrointestinal Bleeding
  • +3 more
  • Push enteroscopy
  • Toronto, Ontario, Canada
    St. Michael's Hospital
Feb 7, 2023

Malignant CNS Tumor Trial in Rochester (drug, other, procedure)

Not yet recruiting
  • Malignant Central Nervous System Neoplasm
  • Anhydrous Enol-oxaloacetate
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 31, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Healthy Trial in Nottingham (Ofev®, Nintedanib formulation 1, Nintedanib formulation 2)

Recruiting
  • Healthy
  • Nottingham, United Kingdom
    Quotient Sciences
Aug 9, 2022

Stillbirth, Delivery Complication, Delivery Delayed Trial in Dar Es Salaam (The PartoMa guidelines and training)

Recruiting
  • Stillbirth
  • +5 more
  • The PartoMa guidelines and training
  • Dar Es Salaam, Tanzania
    Mbagala Ragi Tatu Hospital
Oct 19, 2021

Rare Ocular Diseases

Recruiting
  • Retinitis Pigmentosa
  • +4 more
    • Barcelona, Spain
      Institut de la màcula
    Feb 28, 2022

    Oropharyngeal Cancer, Supraglottic Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Trial in Worldwide

    Recruiting
    • Oropharyngeal Cancer
    • +2 more
    • Intensity-Modulated Radiation Therapy (IMRT)
    • Trans Oral Surgery (TOS)
    • Namur, Yvoir, Belgium
    • +31 more
    Jul 27, 2022

    Nasopharyngeal Tumors Trial in China (Camrelizumab)

    Recruiting
    • Nasopharyngeal Neoplasms
    • Foshan, Guangdong, China
    • +10 more
    May 3, 2022

    Healthy Trial in Nottingham (BI 685509 oral formulation prototypes, BI 685509 standard oral formulation)

    Completed
    • Healthy
    • R1: Reference Product X
    • +12 more
    • Nottingham, United Kingdom
      Quotient Sciences
    Dec 7, 2022

    In Hospital Mortality Trial in Uxbridge, London (Explicit case note review checklist (nurse), Explicit case note review

    Active, not recruiting
    • In Hospital Mortality
    • Explicit case note review checklist (nurse)
    • +2 more
    • Uxbridge, Middlesex, United Kingdom
    • +2 more
    May 4, 2022

    Shigellosis Trial in Kericho, Kilifi (Shigella 4V, MenACWY, Rabies)

    Completed
    • Shigellosis
    • Shigella 4V
    • +4 more
    • Kericho, Kenya
    • +1 more
    Dec 7, 2022

    Statistical Parametric Mapping for Stroke and Trans-tibial

    Completed
    • Stroke
    • Amputation
    • 3D Gait Analysis with Statistical Parametric Mapping
    • Singapore, Singapore
      Tan Tock Seng Hospital
    Oct 20, 2021

    Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Buffalo (Best Practice,

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • +8 more
    • Best Practice
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 29, 2022

    Acute Ischemic Stroke Trial in France (Endovascular treatment in addition of best medical treatment.)

    Not yet recruiting
    • Acute Ischemic Stroke
    • Endovascular treatment in addition of best medical treatment.
    • Bordeaux, France
    • +8 more
    Sep 13, 2022

    Obese, Analgesia Trial in São José Dos Campos, São Paulo (Lactate ringer group, Magnesium sulfate dose through real weight

    Not yet recruiting
    • Obese
    • Analgesia
    • Lactate ringer group
    • +2 more
    • São José Dos Campos, SP, Brazil
    • +1 more
    Mar 2, 2022

    Urothelial Carcinoma Trial in Italy (Niraparib, Best supportive care)

    Completed
    • Urothelial Carcinoma
    • Alba, Italy
    • +19 more
    May 16, 2022